Clinical Trial Update: Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Nabiximols Oromucosal Spray for spasticity in multiple sclerosis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis - Spasticity

Drugs mentioned

• Nabiximols Oromucosal Spray (nabiximols)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Spasticity in Participants With Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2023-07-20